itraconazole has been researched along with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Byard, RW; Ellis, DH; Moore, L; Suppiah, R; Toogood, IR | 1 |
Fitzsimons, E; Gillies, J; Hung, KA; Soutar, R | 1 |
2 other study(ies) available for itraconazole and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Complete eradication of Aspergillus fumigatus from the lung in an immunocompromised patient by oral itraconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Neutropenia; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
Severe vincristine toxicity in combination with itraconazole.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspergillosis; Contraindications; Doxorubicin; Drug Interactions; Enteric Nervous System; Female; Humans; Hyponatremia; Inactivation, Metabolic; Inappropriate ADH Syndrome; Intestinal Pseudo-Obstruction; Itraconazole; Liver; Male; Middle Aged; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine | 1998 |